Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil

PLoS ONE

Volumn 12, Issue 6, 2017, Pages

  Sartori, Ana L ^a,b   Minamisava, Ruth ^a   Bierrenbach, Ana L ^a   Toscano, Cristiana M ^a   Afonso, Eliane T ^a   Morais Neto, Otaliba L ^a   Antunes, José L F ^c   Cristo, Elier B ^d   Andrade, Ana Lucia ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Advisor of the Secretariat of Health   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DEVELOPING COUNTRY; DRUG EFFICACY; FEMALE; HEALTH IMPACT ASSESSMENT; HUMAN; ICD-10; INFANT; INFECTION PREVENTION; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; OUTPATIENT CARE; PUBLIC HEALTH SERVICE; SEASONAL VARIATION; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VACCINATION; IMMUNOLOGY; OUTPATIENT; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

BRAZIL; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; OTITIS MEDIA; OUTPATIENTS; PNEUMOCOCCAL VACCINES; VACCINATION;

EID: 85020436052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0179222     Document Type: Article

References (60)

1. Arguedas A, Kvaerner K, Liese J, Schilder AG, Pelton SI. Otitis media across nine countries: disease burden and management. Int J Pediatr Otorhinolaryngol. 2010; 74(12):1419-24. https://doi.org/10.1016/j.ijporl.2010.09.022 PMID: 20965578.
2. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009; 302(7):758-66. https://doi.org/10.1001/jama.2009.1163 PMID: 19690308; PubMed Central PMCID: PMC4818952.
3. Greenberg D, Bilenko N, Liss Z, Shagan T, Zamir O, Dagan R. The burden of acute otitis media on the patient and the family. Eur J Pediatr. 2003; 162(9):576-81. https://doi.org/10.1007/s00431-003-1260-5 PMID: 12819964.
4. Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. https://doi.org/10.1016/S0140-6736(15)60692-4 PMID: 26063472; PubMed Central PMCID: PMC4561509.
5. Bardach A, Ciapponi A, Garcia-Marti S, Glujovsky D, Mazzoni A, Fayad A, et al. Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol. 2011; 75(9):1062-70. https://doi.org/10.1016/j.ijporl.2011.05.014 PMID: 21665297.
6. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004; 23(9):824-8. PMID: 15361720.
7. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989; 160(1):83-94. PMID: 2732519.
8. Wolleswinkel-van den Bosch JH, Stolk EA, Francois M, Gasparini R, Brosa M. The health care burden and societal impact of acute otitis media in seven European countries: results of an Internet survey. Vaccine. 2010; 28 Suppl 6:G39-52. https://doi.org/10.1016/j.vaccine.2010.06.014 PMID: 21075269.
9. Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014; 59(12):1724-32. https://doi.org/10.1093/cid/ciu683 PMID: 25159581.
10. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005; 40(12):1738-44. https://doi.org/10.1086/ 429908 PMID: 15909260.
11. Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, et al. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J. 2011; 30(7):551-5. https://doi.org/10.1097/INF.0b013e31821038d9 PMID: 21297521.
12. Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev. 2014;(4):CD001480. https://doi.org/10.1002/14651858.CD001480.pub4 PMID: 24696098.
13. Taylor S, Marchisio P, Vergison A, Harriague J, Hausdorff WP, Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis. 2012; 54(12):1765-73. https://doi.org/10.1093/cid/cis292 PMID: 22423134; PubMed Central PMCID: PMC3357481.
14. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006; 118(3):865-73. https://doi.org/10.1542/peds.2006-0492 PMID: 16950975.
15. Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care use in the United States, 2001-2011. JAMA Pediatr. 2014; 168(1):68-75. https://doi.org/10.1001/jamapediatrics.2013.3924 PMID: 24276262; PubMed Central PMCID: PMC3947317.
16. Singleton RJ, Holman RC, Plant R, Yorita KL, Holve S, Paisano EL, et al. Trends in otitis media and myringtomy with tube placement among American Indian/Alaska native children and the US general population of children. Pediatr Infect Dis J. 2009; 28(2):102-7. https://doi.org/10.1097/INF. 0b013e318188d079 PMID: 19131901.
17. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008; 121(2):253-60. https://doi.org/10.1542/peds.2007-0619 PMID: 18245415.
18. Sigurdsson S, Kristinsson KG, Erlendsdottir H, Hrafnkelsson B, Haraldsson A. Decreased Incidence of Respiratory Infections in Children After Vaccination with Ten-valent Pneumococcal Vaccine. Pediatr Infect Dis J. 2015; 34(12):1385-90. https://doi.org/10.1097/INF.0000000000000899 PMID: 26780024.
19. Macinko J, Harris MJ. Brazil's family health strategy - delivering community-based primary care in a universal health system. N Engl J Med. 2015; 372(23):2177-81. https://doi.org/10.1056/ NEJMp1501140 PMID: 26039598.
20. Ministry of Health of Brazil. National Health Agency. Beneficiary Information System 2015 [cited 2016 Apr 12]. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2012/f16.def.
21. Ministry of Health of Brazil. National immunization program. [Technical inform of 10-valent pneumococcal vaccine (conjugate)] 2010 [cited 2017 Apr 12]. Available from: http://portal.saude.gov.br/portal/ arquivos/pdf/intro-pneumococica10-val-04-02-10-ver-final.pdf
22. Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsene JP, et al. Immunogenicity of the 10- valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J. 2009; 28(4 Suppl):S66-76. https://doi.org/10.1097/INF.0b013e318199f8ef PMID: 19325449.
23. Afonso ET, Minamisava R, Bierrenbach AL, Escalante JJ, Alencar AP, Domingues CM, et al. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil. Emerg Infect Dis. 2013; 19 (4):589-97. https://doi.org/10.3201/eid1904.121198 PMID: 23628462; PubMed Central PMCID: PMC3647414.
24. Andrade AL, Minamisava R, Policena G, Cristo EB, Domingues CM, de Cunto Brandileone MC, et al. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis. Hum Vaccin Immunother. 2016; 12(2):285-92. https://doi.org/10.1080/21645515.2015.1117713 PMID: 26905679; PubMed Central PMCID: PMC5049745.
25. Andrade AL, Ternes YM, Vieira MA, Moreira WG, Lamaro-Cardoso J, Kipnis A, et al. Direct effect of 10- valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil. PLoS One. 2014; 9(6):e98128. https://doi.org/10.1371/journal.pone.0098128 PMID: 24892409; PubMed Central PMCID: PMC4043727.
26. Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, et al. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med. 2014; 2(6):464-71. https://doi.org/10.1016/S2213-2600(14)70060-8 PMID: 24726406.
27. Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, et al. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction. Vaccine. 2014; 32(35):4495-9. https://doi.org/10.1016/j.vaccine.2014.06.042 PMID: 24958703.
28. Leach AJ, Wigger C, Andrews R, Chatfield M, Smith-Vaughan H, Morris PS. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC pediatrics. 2014; 14:200. https://doi.org/10.1186/1471-2431-14-200 PMID: 25109288; PubMed Central PMCID: PMC4149294.
29. Oliveira JR, Bouzas ML, Cardoso MR, Barral A, Nascimento-Carvalho C, Acute Respiratory I, et al. Frequency of complications and the effects of pneumococcal vaccination in young children with acute respiratory tract infection. Vaccine. 2016; 34(23):2556-61. https://doi.org/10.1016/j.vaccine.2016.04.015 PMID: 27102819.
30. Ferreira-Filho JBdS Horridge MJ. Economic Integration, Poverty and Regional Inequality in Brazil. RBE. 2006; 60(4):363-87. https://doi.org/10.1590/S0034-71402006000400003
31. IBGE. National household sample survey: synthesis of indicators 2013 [Pesquisa nacional por amostra de domicílios: síntese de indicadores 2013]. 2 ed: Brazilian Institute of Geography and Statistics; 2015.
32. IBGE. Resident population: Brazilian Institute of Geography and Statistics; 2015 [cited 2017 Apr 12]. Available from: http://www.ibge.gov.br/home/estatistica/populacao/estimativa2012/estimativa-tcu. shtm.
33. Shei A, Costa F, Reis MG, Ko AI. The impact of Brazil's Bolsa Familia conditional cash transfer program on children's health care utilization and health outcomes. BMC Int Health Hum Rights. 2014; 14:10. https://doi.org/10.1186/1472-698X-14-10 PMID: 24690131; PubMed Central PMCID: PMC4021270.
34. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision 2016 [cited 2017 Apr 12]. Available from: http://apps.who.int/classifications/icd10/ browse/2016/en.
35. IBGE. Census: Brazilian Institute of Geography and Statistics; 2016 [cited 2017 Apr 12]. Available from: http://downloads.ibge.gov.br/downloads-estatisticas.htm.
36. Ministry of Health of Brazil. Immunizations. [Coverage - Goias State]: DATASUS; 2016 [cited 2017 Apr 12]. Available from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?pni/cnv/cpnigo.def.
37. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000; 19(3):187-95. PMID: 10749457.
38. Azevedo LC, Toscano CM, Bierrenbach AL. Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines. PLoS One. 2013; 8(6):e64524. https://doi.org/10.1371/journal.pone.0064524 PMID: 23823579; PubMed Central PMCID: PMC3688798.
39. Oliveira GP, Bierrenbach AL, Camargo KRJ, Coeli CM, Pinheiro RS. Accuracy of probabilistic and deterministic record linkage: the case of tuberculosis. Rev Saude Publica. 2016; 50:49. https://doi.org/10.1590/S1518-8787.2016050006327 PMID: 27556963; PubMed Central PMCID: PMC4988803.
40. Snedecor GW, Cochran WG. Statistical methods. 8 ed. Ames, Iowa: Iowa State University Press; 1989. 503 p.
41. Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Academic pediatrics. 2013; 13(6 Suppl):S38-44. https://doi.org/10.1016/j.acap.2013.08.002 PMID: 24268083.
42. Thompson WW, Ridenhour BL, Barile JP, Shay DK. Time-series analyses of count data to estimate the burden of seasonal infectious diseases. Epidemiology. 2012; 23(6):839-42; discussion 43-4. https://doi.org/10.1097/EDE.0b013e31826cc1df PMID: 23038110.
43. Sgambatti S, Minamisava R, Bierrenbach AL, Toscano CM, Vieira MA, Policena G, et al. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance. Vaccine. 2016; 34(5):663-70. https://doi.org/10.1016/j.vaccine.2015.12.007 PMID: 26706272.
44. Ansaldi F, Sticchi L, Durando P, Carloni R, Oreste P, Vercelli M, et al. Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy. J Int Med Res. 2008; 36(6):1255-60. https://doi.org/10.1177/147323000803600612 PMID: 19094434.
45. Fortunato F, Martinelli D, Cappelli MG, Cozza V, Prato R. Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children. J Immunol Res. 2015; 2015:206757. https://doi.org/10.1155/2015/206757 PMID: 26351644; PubMed Central PMCID: PMC4553180.
46. Lau WC, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, et al. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine. 2015; 33(39):5072-9. https://doi.org/10.1016/j.vaccine.2015.08.022 PMID: 26297875.
47. Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007; 119(4):707-15. https://doi.org/10.1542/peds.2006-2138 PMID: 17403841.
48. Suarez V, Michel F, Toscano CM, Bierrenbach AL, Gonzales M, Alencar AP, et al. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses. Vaccine. 2016; 34(39):4738-43. https://doi.org/10.1016/j.vaccine.2016.07.027 PMID: 27521230.
49. Wals PD, Carbon M, Sevin E, Deceuninck G, Ouakki M. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J. 2009; 28(9):e271-5. https://doi.org/10.1097/INF.0b013e3181bad212 PMID: 19710582.
50. Poehling KA, Lafleur BJ, Szilagyi PG, Edwards KM, Mitchel E, Barth R, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004; 114(3):755-61. https://doi.org/10.1542/peds.2003-0592-F PMID: 15342850.
51. Leach AJ, Wigger C, Hare K, Hampton V, Beissbarth J, Andrews R, et al. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10- valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. BMC pediatrics. 2015; 15:162. https://doi.org/10.1186/s12887-015-0483-8 PMID: 26482232; PubMed Central PMCID: PMC4615539.
52. Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014; 33 Suppl 2:S161-71. https://doi.org/10.1097/INF. 0000000000000084 PMID: 24336058; PubMed Central PMCID: PMC3940524.
53. Whitney CG, Goldblatt D, O'Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infect Dis J. 2014; 33 Suppl 2:S172-81. https://doi.org/10.1097/INF. 0000000000000076 PMID: 24336059; PubMed Central PMCID: PMC3940379.
54. Syrjanen RK, Herva EE, Makela PH, Puhakka HJ, Auranen KJ, Takala AK, et al. The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age. Pediatr Infect Dis J. 2006; 25(11):1032-6. https://doi.org/10.1097/01.inf.0000241097.37428.1d PMID: 17072126.
55. Flasche S, Givon-Lavi N, Dagan R. Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media. Am J Epidemiol. 2016; 184(9):652-9. https://doi.org/10.1093/aje/kww012 PMID: 27744387.
56. Malta DC, Santos MA, Stopa SR, Vieira JE, Melo EA, dos Reis AA. Family Health Strategy Coverage in Brazil, according to the National Health Survey, 2013. Cien Saude Colet. 2016; 21(2):327-38. https://doi.org/10.1590/1413-81232015212.23602015 PMID: 26910142.
57. Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet. 2011; 377(9779):1778-97. https://doi.org/10.1016/S0140-6736(11)60054-8 PMID: 21561655.
58. Rocha R, Soares RR. Evaluating the impact of community-based health interventions: evidence from Brazil's Family Health Program. Health Econ. 2010; 19 Suppl:126-58. https://doi.org/10.1002/hec.1607 PMID: 20803631.
59. Paradise JL, Rockette HE, Colborn DK, Bernard BS, Smith CG, Kurs-Lasky M, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997; 99(3):318-33. PMID: 9041282.
60. Brazilian Observatory of the National Education Plan. Percentage of children up to 3 years old attending daycare. Goias 2016 [cited 2017 Apr 12]. Available from: http://tabnet.datasus.gov.br/cgi/deftohtm. exe?pni/cnv/cpnigo.def.